Our consultants are not only technical experts when it comes to Pharmacometrics and PBPK-QSP, they are also excellent strategists when it comes to how to combine a series of different modeling approaches to support a holistic drug development strategy.
Benefits we have seen achieved with utilizing our MIDD solutions include augmented clinical teams with embedded scientists, replaced/reduced/optimized trials with appropriate strategies, and increased visibility of MIDD within the organization through involvement of external experts.